[go: up one dir, main page]

PE20070430A1 - Composiciones topicas que comprenden o-desmetilvenlafaxina (odv) - Google Patents

Composiciones topicas que comprenden o-desmetilvenlafaxina (odv)

Info

Publication number
PE20070430A1
PE20070430A1 PE2006001079A PE2006001079A PE20070430A1 PE 20070430 A1 PE20070430 A1 PE 20070430A1 PE 2006001079 A PE2006001079 A PE 2006001079A PE 2006001079 A PE2006001079 A PE 2006001079A PE 20070430 A1 PE20070430 A1 PE 20070430A1
Authority
PE
Peru
Prior art keywords
desmetilvenlafaxine
odv
compositions including
topical compositions
composition
Prior art date
Application number
PE2006001079A
Other languages
English (en)
Inventor
Rao Tatapudy
Syed M Shah
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37517243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20070430(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20070430A1 publication Critical patent/PE20070430A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) O-DESMETIL VENLAFAXINA EN UNA CANTIDAD DE 5MG A 500MG; B) UN POTENCIADOR DE LA ABSORCION TAL COMO PENTADECALACTONA, 1,3-DIOXOLANOS, 1,3-DIOXANOS O UNA MEZCLA DE LOS MISMOS; C) UN VEHICULO O EXCIPIENTE TAL COMO POLIETILENGLICOL, GLICERINA, PROPILENGLICOL, ACRILATOS, ENTRE OTROS; Y D) OTRO AGENTE FARMACOLOGICAMENTE ACTIVO TAL COMO ANALGESICO, MIORRELAJANTE, ANTIDEPRESIVO, ENTRE OTROS. DICHA COMPOSICION SE PRESENTA COMO CREMA, LOCION, UNGUENTO, ENTRE OTROS, SIENDO UTIL EN EL TRATAMIENTO DE SINTOMAS VASOMOTORES TAL COMO SOFOCOS, INSOMNIO O IRRITABILIDAD, Y EL DOLOR
PE2006001079A 2005-09-07 2006-09-07 Composiciones topicas que comprenden o-desmetilvenlafaxina (odv) PE20070430A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71540005P 2005-09-07 2005-09-07

Publications (1)

Publication Number Publication Date
PE20070430A1 true PE20070430A1 (es) 2007-05-18

Family

ID=37517243

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001079A PE20070430A1 (es) 2005-09-07 2006-09-07 Composiciones topicas que comprenden o-desmetilvenlafaxina (odv)

Country Status (18)

Country Link
US (1) US20070054964A1 (es)
EP (1) EP1924251A1 (es)
JP (1) JP2009507078A (es)
KR (1) KR20080041695A (es)
CN (1) CN101300002A (es)
AR (1) AR055629A1 (es)
AU (1) AU2006287580A1 (es)
BR (1) BRPI0615769A2 (es)
CA (1) CA2620164A1 (es)
CR (1) CR9751A (es)
EC (1) ECSP088251A (es)
GT (1) GT200600397A (es)
IL (1) IL189598A0 (es)
NO (1) NO20080950L (es)
PE (1) PE20070430A1 (es)
RU (1) RU2008106932A (es)
TW (1) TW200744566A (es)
WO (1) WO2007030537A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2692738A1 (en) * 2007-07-12 2009-01-15 Dr. Reddy's Laboratories, Ltd. O-desmethylvenlafaxine
US20100330172A1 (en) * 2007-10-16 2010-12-30 Alphapharm Pty Ltd Controlled-release pharmaceutical formulation
EP2212301B1 (en) * 2007-11-28 2012-02-29 Fresenius Kabi Oncology Limited An improved process for preparation of letrozole and its intermediates
EP2085377A1 (en) 2008-01-29 2009-08-05 LEK Pharmaceuticals D.D. Novel salts of O-desmethyl-venlafaxine
WO2009155488A2 (en) * 2008-06-19 2009-12-23 Segrub, Llc Novel oxalate salt and crystal of o-desmethylvenlafaxine
WO2010028130A2 (en) * 2008-09-03 2010-03-11 Concert Pharmaceuticals, Inc. Antidepressant compounds
EP2621891B1 (en) * 2010-10-01 2019-11-06 Shan Dong Luye Pharmaceutical Co., Ltd. Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
WO2013063794A1 (en) * 2011-11-04 2013-05-10 Oil Crops Research Institute, Chinese Academy Of Agricultural Sciences A growth regulatory factor gene grf2 derived from brassica napus and the use thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
US4861764A (en) * 1986-11-17 1989-08-29 Macro Chem. Corp. Percutaneous absorption enhancers, compositions containing same and method of use
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
CZ20013607A3 (cs) * 1999-04-06 2002-06-12 Sepracor Inc. Farmaceutický prostředek
US20020192302A1 (en) * 1999-12-16 2002-12-19 Tsung-Min Hsu Transdermal and topical administration of antidepressant drugs using basic enhancers
DE10042412B4 (de) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung
HN2002000030A (es) * 2001-02-12 2004-06-07 Wyeth Corp Nueva sal succinato de o-desmetil-venlafaxina
KR20050013125A (ko) * 2002-06-10 2005-02-02 와이어쓰 Ｏ-데스메틸-벤라팍신의 신규한 포르메이트 염
US7345096B2 (en) * 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
JP2007503435A (ja) * 2003-08-26 2007-02-22 ベクトン・ディキンソン・アンド・カンパニー 治療薬の皮内送達法
PL1691811T3 (pl) * 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
US20060013866A1 (en) * 2004-07-16 2006-01-19 Carter Stephen G Transdermal drug delivery formulations with optimal amounts of vasodilators therein

Also Published As

Publication number Publication date
CA2620164A1 (en) 2007-03-15
KR20080041695A (ko) 2008-05-13
TW200744566A (en) 2007-12-16
BRPI0615769A2 (pt) 2011-05-24
IL189598A0 (en) 2008-08-07
AR055629A1 (es) 2007-08-29
RU2008106932A (ru) 2009-10-20
AU2006287580A1 (en) 2007-03-15
EP1924251A1 (en) 2008-05-28
CN101300002A (zh) 2008-11-05
GT200600397A (es) 2007-08-28
US20070054964A1 (en) 2007-03-08
ECSP088251A (es) 2008-04-28
JP2009507078A (ja) 2009-02-19
NO20080950L (no) 2008-05-26
WO2007030537A1 (en) 2007-03-15
CR9751A (es) 2008-05-22

Similar Documents

Publication Publication Date Title
MX2011011514A (es) Formulaciones de canabidiol y metodos para utilizarlas.
PE20140936A1 (es) Composiciones transdermicas de ibuprofeno y metodos de uso de las mismas
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
AR021539A1 (es) Preparaciones topicas anhidras para la piel
AR046878A1 (es) Agente endoparasiticida para administracion topica
AR073123A1 (es) Composicion farmaceutica que comprende un taxano sustancialmente amorfo para utilizarse en el tratamiento de la enfermedad neoplasica
GT199900203A (es) Composiciones de celecoxib.
CL2011000653A1 (es) Compuestos derivados del acido 1-amino-2-ciclobutil-etil-boronico; composicion farmaceutica; polvo liofilizado y metodo para obtenerlo; y uso en el tratamiento del cancer.
PE20080374A1 (es) Composiciones farmaceuticas de ropinirol
AR063109A1 (es) Terapias topicas para la mucositis oral y otras afecciones
AR069572A1 (es) Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
MX393613B (es) Composiciones de gel para administracion transdermica para maximizar las concentraciones de farmaco en el estrato corneo y suero, y metodos de uso de las mismas.
PE20070430A1 (es) Composiciones topicas que comprenden o-desmetilvenlafaxina (odv)
PE20150773A1 (es) Composiciones farmaceuticas para la liberacion sostenida de fenilefrina
CY1109507T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
BR112012015437A2 (pt) composição tópica substancialmente anidra de armazenamento estável
PE20081794A1 (es) Composicion farmaceutica que comprende un agente calcilitico
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
AR033390A1 (es) Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes
PE20070432A1 (es) Dispositivos de administracion transdermicas de farmacos que contienen o-desmetilvenlafaxina (odv) o sus sales
PE20070525A1 (es) Composicion farmaceutica a base de miel
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient
AR035064A1 (es) 3-(1-metil-3-indolil)-4-(1-metil-6-nitro-3-indolil)-1h-pirrol-2,5-diona, en forma amorfa, procesos para prepararla, composicion farmaceutica que la comprende y uso de dicho compuesto en la fabricacion de medicamentos
AR033596A1 (es) Composicion farmaceutica para inyeccion intramuscular que contiene loxoprofeno

Legal Events

Date Code Title Description
FC Refusal